Feature Type | Standardized |
Nominal ANOVA |
||||
---|---|---|---|---|---|---|
mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.007 | 0.9 |
mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.0045 | 0.9 |
mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | 0.0049 | 0.9 |
mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.9 |
mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.0047 | 0.9 |